To clarify the underlying mechanisms of
IgA nephropathy (IgAN) induced by
nivalenol (NIV), a
trichothecene mycotoxin, we examined the time and dose relationships of glomerular deposition of
IgA by NIV in BALB/c mice (Experiment 1), and also evaluated the modification of NIV on spontaneous IgAN in an inbred murine model, a high
IgA strain (HIGA), during its early stage of pathogenesis (Experiment 2). In Experiment 1, female BALB/c mice were given a diet containing 0, 12, or 24 ppm concentration of NIV for 4 or 8 weeks. An increase in serum
IgA levels was found at 24 ppm from 4 weeks. At week 8 of treatment, dose-dependent increases in serum
IgA levels and glomerular deposition of
IgA and
IgG were observed without accompanying histopathological glomerular changes. On the other hand, in Experiment 2, control HIGA mice exhibited rather high levels of serum
IgA as compared with BALB/c mice from 4 weeks of experiment as well as glomerular deposition of
IgA and
IgG and mesangial proliferation as revealed at week 8. NIV at 24ppm further increased serum
IgA in this strain; however, it did not enhance glomerular
immunoglobulin deposition or histopathological lesion. These results suggest that NIV-induced increase of serum
IgA levels may be primarily responsible for glomerular
immunoglobulin deposition; however, NIV does not enhance glomerular
IgA deposition that may lead to exacerbation of predisposed IgAN in the short term, irrespective of the further elevation of serum
IgA from the high basal levels.